Sudeep Pharma IPO
GMP, Subscription, Price, Dates & Financial Details
Sudeep Pharma Limited, incorporated in 1989, is a leading manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients, supplying products to over 100 countries.OperationsThe company operates six manufacturing facilities with a combined production capacity of…
Open Date
Fri, 21 Nov 2025
Close Date
Tue, 25 Nov 2025
Price Band
₹ 563 – 593
Lot Size
25
Issue Size
₹ 895.00 Cr
Minimum Investment
₹ 14,825 (25 Shares)
Grey Market Premium Analysis
Day Wise GMP→Unofficial premium quoted in the grey market, tracked daily against the price band cap.
Grey market trading is unregulated. GMP figures are indicative only and should not be the sole basis for investment decisions - treat as a sentiment indicator, not a guarantee.
IPO Details
Sudeep Pharma IPO has successfully completed its IPO process and is now listed on the NSE and BSE. According to the Red Herring Prospectus (RHP), the IPO was a book-built issue with a total issue size of ₹895.00 Crore, comprising a fresh issue of 16.02 Lakh equity shares aggregating to ₹95.00 Crore and an offer for sale (OFS) of 1.35 Crore equity shares aggregating to ₹800.00 Crore by the existing shareholders.
The Sudeep Pharma IPO remained open for subscription from November 21, 2025, to November 25, 2025. The basis of allotment was finalized on November 26, 2025, and the company's shares were listed on the NSE and BSE on November 28, 2025.
The company had fixed the price band at ₹563 to ₹593 per share, with a lot size of 25 shares. Retail investors were required to make a minimum investment of ₹14,825 (based on the upper price band) to apply for one lot.
MUFG Intime India Private Limited served as the registrar to the issue. ICICI Securities Limited, and IIFL Capital Services Limited acted as the Book Running Lead Managers (BRLMs) to the issue.
With the successful completion of the IPO process, Sudeep Pharma Limited is now a publicly listed company on the NSE and BSE. Investors can track the company's share price, trading performance, financial results, and corporate announcements through the stock exchanges.
Sudeep Pharma IPO Timeline (Tentative)
- IPO Open Date
- Fri, 21 Nov 25
- IPO Close Date
- Tue, 25 Nov 25
- Basis of Allotment
- Wed, 26 Nov 25
- Initiation of Refunds
- Thu, 27 Nov 25
- Credit of Shares to Demat
- Thu, 27 Nov 25
- Listing Date
- Fri, 28 Nov 25 — NSE & BSE
Open Date
21 November 2025
Close Date
25 November 2025
Basis Of Allotment
26 November 2025
Listing Date
28 November 2025
IPO Subscription
Check Live Subscription →The Sudeep Pharma IPO has received bids for 99,01,00,150 shares against 1,05,64,926 shares offered, resulting in an overall subscription of 93.72x. the NII category is subscribed 116.72x, Retail Investors 15.65x, and QIBs 213.08x. Within the NII category, BNII is subscribed 134.91x, while SNII is subscribed 80.33x.
QIB
213.08x
NII
116.72x
BNII
134.91x
SNII
80.33x
RII
15.65x
Total
93.72x
IPO Reservations
The Retail Individual Investor (RII) category has the highest allocation with 52,82,463 shares, representing 50% of the total issue. Qualified Institutional Buyers (QIBs) are allocated 30,18,550 shares (28.57%), while Non-Institutional Investors (NIIs) receive 22,63,913 shares (21.43%).
| Category | Shares Offered | Shares Offered % |
|---|---|---|
| Qualified Institutions | 3,018,550 | 28.57% |
| Non-Institutional | 2,263,913 | 21.43% |
| BNII | 1,509,276 | 14.29% |
| SNII | 754,637 | 7.14% |
| Retail Investors | 5,282,463 | 50% |
| Total | 10,564,926 | 100% |
Financials Details(₹ in Crores)
| Particular | 30 Jun 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 922.26 | 717.17 | 513.87 | 420.11 |
| Revenue | 130.08 | 511.33 | 465.38 | 438.26 |
| Profit After Tax | 31.27 | 138.69 | 133.15 | 62.32 |
| Net Worth | 688.32 | 497.53 | 359.07 | 226.29 |
| Reserve & Surplus | 668.52 | 481.11 | 354.59 | 221.88 |
| Total Borrowings | 135.97 | 135.25 | 75.03 | 82.26 |
Financials Performance
Performance Indicators
EPS Pre
Earnings per share before the IPO.
P/E Pre
IPO Offer Price ÷ EPS Pre.
EPS Post
Expected earnings per share after the IPO..
P/E (Post Issue)
IPO Offer Price ÷ EPS Post.
Sudeep Pharma Limited KPI Information
| Particular | KPI as of Mon | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Debt / Equity | 0.2 | 0.17 | 0.32 |
| RoNW % | 27.88 | 27.91 | 30.59 |
| Pat Margin % | 27.63 | 37.09 | 27.54 |
Peers Comparison
No Peer Comparision Available
About Sudeep Pharma Limited
Sudeep Pharma Limited, incorporated in 1989, is a leading manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients, supplying products to over 100 countries.
Operations
- The company operates six manufacturing facilities with a combined production capacity of 50,000 MT.
- It specializes in producing high-quality mineral salts, including calcium, iron, magnesium, zinc, potassium, and sodium derivatives.
- With a portfolio of more than 200 products, Sudeep Pharma serves a diverse clientele across the pharmaceutical, food, and nutrition industries.
Research & Development
- The company has strong R&D capabilities supported by in-house laboratories and pilot-scale production facilities.
- Its R&D efforts focus on innovation in mineral salts, pharmaceutical excipients, and specialty ingredients.
Product Portfolio
- Pharmaceutical, Food, and Nutrition Business
- Specialty Ingredients Business
- Triturates
Human Resources
- As of December 31, 2024, Sudeep Pharma Limited employed 704 permanent employees.
Sudeep Pharma IPO Promoters
- Sujit Jaysukh Bhayani
- Shanil Sujit Bhayani
- Avani Sujit Bhayani
- Sujeet Jaysukh Bhayani HUF
- Riva Resources Private Limited
- Bhayani Family Trust
Promoters Holding
Holding Pre Issue
89.37%
Holding Post Issue
76.15%
Sudeep Pharma IPO Objective
The Company Sudeep Pharma IPO proposes to utilise the Net Proceeds from the Issue towards the following objects.
- Capital expenditure towards procurement of machinery for our production line located at Nandesari Facility I
- General corporate purpose
Sudeep Pharma Limited Address / Contact Details
Sudeep Pharma Ltd.
129/1/A,
GIDC Estate,Nandesari,
Vadodara, Gujarat, 391340
Phone: +91 265 284 0656
Email: cs.sudeep@sudeepgroup.com
Website: https://www.sudeeppharma.com/
IPO Snapshot
Sudeep Pharma IPO Lot Size
The Sudeep Pharma IPO has a lot size of 25 shares. Retail investors require a minimum investment of ₹14,825 by applying for 1 lot (25 shares). The maximum application allowed for the retail category is 13 lots (325 shares), requiring an investment of ₹1,92,725.
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 25 | 14,825.00 |
| Retail (Max) | 13 | 325 | 192,725.00 |
| S-HNI (Min) | 14 | 350 | 207,550.00 |
| S-HNI (Max) | 67 | 1,675 | 993,275.00 |
| B-HNI (Min) | 68 | 1,700 | 1,008,100.00 |
Issue Reservation
- QIB — 28.57%
- NII — 21.43%
- RII — 50%
Book Running Lead Managers
- ICICI Securities Limited
- IIFL Capital Services Limited
IPO Documents & Links
Explore More IPOs
Currently Open
Coming Up Next
Disclaimer: This data is for informational purposes only and does not constitute investment advice.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Sudeep Pharma IPO?
Sudeep Pharma IPO is a Book-building IPO with a total issue size of ₹895 crore. The Sudeep Pharma IPO price band is ₹563 to 593 per share. The Sudeep Pharma IPO subscription opens on Fri, Nov 21, 2025, and closes on Tue, Nov 25, 2025. The Sudeep Pharma IPO will be listed on the BSE,NSE. MUFG Intime India Private Limited is the registrar for the Sudeep Pharma IPO.
When will the Sudeep Pharma IPO open for subscription?
The Sudeep Pharma IPO opens on Fri, Nov 21, 2025 and closes on Tue, Nov 25, 2025
What is Sudeep Pharma IPO Price Band?
Sudeep Pharma IPO Price Band is ₹563 to 593 per share.
What is Sudeep Pharma IPO Lot Size?
Sudeep Pharma IPO lot size is 25 shares, Retail investors need a minimum investment of ₹14825 based on the upper price band
What is the minimum investment for Sudeep Pharma IPO?
The minimum investment for Sudeep Pharma IPO is ₹14825, based on one lot of 25 shares at the upper price band of ₹593 per share.
How to apply for Sudeep Pharma IPO?
Investors can apply for the Sudeep Pharma IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Tue, Nov 25, 2025. The application amount remains blocked until the Sudeep Pharma IPO allotment is finalized.
What is Sudeep Pharma IPO Issue Size?
Sudeep Pharma IPO issue size is ₹895 crores.
What is the Sudeep Pharma IPO Allotment Date?
Sudeep Pharma IPO allotment date is Wed, Nov 26, 2025.
Who is the Sudeep Pharma IPO Registrar?
The registrar for Sudeep Pharma IPO is MUFG Intime India Private Limited. Investors can go to MUFG Intime India Private Limited website to check Sudeep Pharma IPO allotment status, refund processing, and other IPO-related information.
What is the Sudeep Pharma IPO GMP?
The Sudeep Pharma IPO GMP (Grey Market Premium) is ₹121 as of Fri, Nov 28, 2025. Based on the upper price band of ₹593 per share, the estimated Sudeep Pharma IPO listing price is ₹714, indicating a potential listing gain of approximately 20.40% over the issue price.
Who is the Sudeep Pharma IPO Lead Manager?
The book-running lead managers (BRLMs) for the Sudeep Pharma IPO are ICICI Securities Limited, and IIFL Capital Services Limited. The lead managers are responsible for managing the IPO process, including issue structuring, regulatory compliance, marketing the public issue, coordinating with investors, and ensuring a smooth listing process. For complete details, investors should refer to the Sudeep Pharma IPO Red Herring Prospectus (RHP).